动/静态条件下PLGA与PLGA/β-TCP多孔支架的降解与释药行为
|
摘要
作为骨组织工程三要素之一的多孔支架,被用作骨细胞分化的模板,与生物活性物质结合,起着支撑、调控和引导细胞与骨组织生长的重要作用。构建具有生物活性的可生物降解多孔支架,对于骨组织的成功修复具有重要意义。
采用热致相分离/粒子洗去法制备聚(丙交酯-co-乙交酯)(PLGA)和PLGA/β-磷酸三钙(β-TCP)多孔支架。支架的孔隙率由致孔剂含量控制。形貌受聚合物溶液浓度和冷冻温度的影响较大。力学性能随致孔剂含量的增加、冷冻温度的降低和溶液浓度的降低而下降。分别在动态(循环压应力)和静态(水浴摇床)条件下考察PLGA和PLGA/β-TCP支架的降解行为。结果表明,循环压应力能明显加速两种支架水解降解,并以此提出了PLGA多孔支架体外受力降解的三阶段模型。细胞实验显示,支架的降解会影响成骨细胞在其上的增殖。
以聚乙二醇单甲醚(mPEG)与L-聚丙交酯的共聚物(PELA)为载体,用复乳法分别制备包载牛血清白蛋白(BSA)和维生素C (Vc)的微球,并借助于溶结后处理法将微球载入PLGA支架孔壁上。考察分别载有BSA和Vc的微球-支架在动/静态条件下的药物释放行为。结果表明,与微球的释放行为相比,微球-支架体系中BSA和Vc的释放速度较慢。循环压应力明显加速药物从微球-支架中的释放。与BSA相比,Vc从PELA微球和微球-支架中均具有较高的释放速度。
分别使用喷雾干燥法和复乳法制备包载地塞米松(Dex)和BSA的PLGA微球。考察合成PLGA的引发剂、LA/GA摩尔比和相对分子质量对Dex和BSA的控释能力。优化组合具有不同释放速度的包载Dex和BSA的PLGA微球,同时载入到PLGA/β-TCP多孔支架内部。结果显示,合成PLGA的引发剂、LA/GA摩尔比、相对分子质量等均影响Dex和BSA从PLGA微球中的释放速度。mPEG引入PLGA微球载体中可以提高药物包封率、减缓药物释放速度。GA含量的增加可以加速药物的释放。相对分子质量越大,药物从微球中释放越慢。双组分药物释放结果表明,通过优化设计,可以实现对Dex和BSA在不同时间段从PLGA/β-TCP多孔支架中不同释放速度和不同释放量的控制。
As one of three factors in bone tissue engineering, a porous scaffold is often used as a template to guide the differentiation of cells. Furthermore, a scaffold containing bioactive factors plays a special important role in successful repair and regeneration of the bone.
In this study, porous poly(lactide-co-glycolide) (PLGA) and PLGA/β-tricalcium phosphate (β-TCP) scaffolds were prepared by thermally induced phase separation and porogen leaching. The porosity of the scaffolds was mainly controlled by the content of porogen, and the morphology was primarily influenced by the freezing temperature and the polymer solution concentration. The compressive properties decreased with increasing the porogen content, decreasing the freezing temperature and diluting the polymer solution concentration. The degradation behaviors of PLGA and PLGA/β-TCP scaffolds were investigated under dynamic condition (cyclic loading) and static condition (water shaking bath), and it was found that cyclic loading could indeed accelerate the degradation rate of the scaffold. The degradation behavior of PLGA scaffolds under dynamic condition showed a three stage degradation model. The viability of osteoblasts cultured on both PLGA and PLGA/β-TCP scaffolds showed a drop tendency with the degradation time of the scaffolds.
Bovine serum albumin (BSA) and vitamin C (Vc), as model drugs, were loaded into poly(ethylene glycol)-b-poly(L-lactide) (PELA) microspheres through the method of double emulsion/solvent evaporation. BSA and Vc-loaded PELA microspheres were incorporated into the PLGA scaffolds by using post-seeding method. The release behavior of BSA and Vc from the microspheres incorporated PLGA scaffold under dynamic and static condition was studied. The results showed that comparing with the drug release from PELA microspheres, the drug release from the microspheres incorporated PLGA scaffold showed a lower release rate and a prolonged release time. And the cyclic loading could speed up the release of the drugs from the scaffold. Meanwhile, Vc with low molecular mass showed higher release rate than BSA from both PELA microspheres and PLGA scaffold.
Dexamethasone (Dex) and BSA contained PLGA microspheres were prepared by spray drying and double emulsion/solvent evaporation respectively. The effect of initiator, molar ratio of lactic acid (LA) and glycolic acid (GA) and relative molecular mass on the drug release rate was investigated. The release behaviors of Dex and BSA from these microspheres were studied. Selected Dex-loaded and BSA-loaded PLGA microspheres with varied release rate were incorporated into PLGA/β-TCP scaffolds. The in vitro release study indicated that the introduction of m-poly(ethylene glycol) in PLGA could improve the drug encapsulation efficiency in microspheres and reduce the drug release rate from the microspheres. Microspheres prepared from PLGA with lower GA content and higher relative molecular mass showed a prolonged drug release profile. The controllable release rate and release amount of Dex and BSA from PLGA/β-TCP scaffolds could be achieved by selecting the drug-loaded microspheres within the matrix having different degradation rate.
采用热致相分离/粒子洗去法制备聚(丙交酯-co-乙交酯)(PLGA)和PLGA/β-磷酸三钙(β-TCP)多孔支架。支架的孔隙率由致孔剂含量控制。形貌受聚合物溶液浓度和冷冻温度的影响较大。力学性能随致孔剂含量的增加、冷冻温度的降低和溶液浓度的降低而下降。分别在动态(循环压应力)和静态(水浴摇床)条件下考察PLGA和PLGA/β-TCP支架的降解行为。结果表明,循环压应力能明显加速两种支架水解降解,并以此提出了PLGA多孔支架体外受力降解的三阶段模型。细胞实验显示,支架的降解会影响成骨细胞在其上的增殖。
以聚乙二醇单甲醚(mPEG)与L-聚丙交酯的共聚物(PELA)为载体,用复乳法分别制备包载牛血清白蛋白(BSA)和维生素C (Vc)的微球,并借助于溶结后处理法将微球载入PLGA支架孔壁上。考察分别载有BSA和Vc的微球-支架在动/静态条件下的药物释放行为。结果表明,与微球的释放行为相比,微球-支架体系中BSA和Vc的释放速度较慢。循环压应力明显加速药物从微球-支架中的释放。与BSA相比,Vc从PELA微球和微球-支架中均具有较高的释放速度。
分别使用喷雾干燥法和复乳法制备包载地塞米松(Dex)和BSA的PLGA微球。考察合成PLGA的引发剂、LA/GA摩尔比和相对分子质量对Dex和BSA的控释能力。优化组合具有不同释放速度的包载Dex和BSA的PLGA微球,同时载入到PLGA/β-TCP多孔支架内部。结果显示,合成PLGA的引发剂、LA/GA摩尔比、相对分子质量等均影响Dex和BSA从PLGA微球中的释放速度。mPEG引入PLGA微球载体中可以提高药物包封率、减缓药物释放速度。GA含量的增加可以加速药物的释放。相对分子质量越大,药物从微球中释放越慢。双组分药物释放结果表明,通过优化设计,可以实现对Dex和BSA在不同时间段从PLGA/β-TCP多孔支架中不同释放速度和不同释放量的控制。
As one of three factors in bone tissue engineering, a porous scaffold is often used as a template to guide the differentiation of cells. Furthermore, a scaffold containing bioactive factors plays a special important role in successful repair and regeneration of the bone.
In this study, porous poly(lactide-co-glycolide) (PLGA) and PLGA/β-tricalcium phosphate (β-TCP) scaffolds were prepared by thermally induced phase separation and porogen leaching. The porosity of the scaffolds was mainly controlled by the content of porogen, and the morphology was primarily influenced by the freezing temperature and the polymer solution concentration. The compressive properties decreased with increasing the porogen content, decreasing the freezing temperature and diluting the polymer solution concentration. The degradation behaviors of PLGA and PLGA/β-TCP scaffolds were investigated under dynamic condition (cyclic loading) and static condition (water shaking bath), and it was found that cyclic loading could indeed accelerate the degradation rate of the scaffold. The degradation behavior of PLGA scaffolds under dynamic condition showed a three stage degradation model. The viability of osteoblasts cultured on both PLGA and PLGA/β-TCP scaffolds showed a drop tendency with the degradation time of the scaffolds.
Bovine serum albumin (BSA) and vitamin C (Vc), as model drugs, were loaded into poly(ethylene glycol)-b-poly(L-lactide) (PELA) microspheres through the method of double emulsion/solvent evaporation. BSA and Vc-loaded PELA microspheres were incorporated into the PLGA scaffolds by using post-seeding method. The release behavior of BSA and Vc from the microspheres incorporated PLGA scaffold under dynamic and static condition was studied. The results showed that comparing with the drug release from PELA microspheres, the drug release from the microspheres incorporated PLGA scaffold showed a lower release rate and a prolonged release time. And the cyclic loading could speed up the release of the drugs from the scaffold. Meanwhile, Vc with low molecular mass showed higher release rate than BSA from both PELA microspheres and PLGA scaffold.
Dexamethasone (Dex) and BSA contained PLGA microspheres were prepared by spray drying and double emulsion/solvent evaporation respectively. The effect of initiator, molar ratio of lactic acid (LA) and glycolic acid (GA) and relative molecular mass on the drug release rate was investigated. The release behaviors of Dex and BSA from these microspheres were studied. Selected Dex-loaded and BSA-loaded PLGA microspheres with varied release rate were incorporated into PLGA/β-TCP scaffolds. The in vitro release study indicated that the introduction of m-poly(ethylene glycol) in PLGA could improve the drug encapsulation efficiency in microspheres and reduce the drug release rate from the microspheres. Microspheres prepared from PLGA with lower GA content and higher relative molecular mass showed a prolonged drug release profile. The controllable release rate and release amount of Dex and BSA from PLGA/β-TCP scaffolds could be achieved by selecting the drug-loaded microspheres within the matrix having different degradation rate.
引文
[1] Hulbert SF. In: Hench LL, Wilson J, editors. An introduction to bioceramics. Singapore: World Scientific, 1993. pp25~40.
[2] Langer R, Vacanti JP. Tissue engineering. Science, 1993, 260(5110): 920~926
[3] Hench LL. Biomaterials: a forecast for the future. Biomaterials, 1998, 19 (16): 1419~1423
[4] Shin HS, Jo SB, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials, 2003, 24 (24): 4353~4364
[5] Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet, 1999, 354(suppl I):32~34
[6] Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chemical Reviews, 2001, 101(7):1869~1879
[7] Putnam AJ, Mooney DJ. Tissue engineering using synthetic extracellular matrices. Nature Medicine, 1996, 2(7):824~826
[8] Marler JJ, Upton J, Langer R, et al. Transplantation of cells in matrices for tissue engineering. Advanced Drug Delivery Reviews, 1998, 33(1-2):165-182
[9] Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends In Biotechnology, 1998, 16(5):224~230
[10] Agrawa CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. Journal of Biomedical Materials Research, 2001, 55(2):141~150
[11] Quaglia F. Bioinspired tissue engineering: The great promise of protein delivery technologies. International Journal of Pharmaceutics, 2008, 364(2) 281~297
[12] Al-Munajjed AA, Plunkett NA, Gleeson JP, et al. Development of a biomimetic collagen-hydroxyapatite scaffold for bone tissue engineering using a SBF immersion technique. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B(2): 584~591
[13] Ye C, Hu P, Ma MX, et al. PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials, 2009, 30(26): 4401~4406
[14] Li XR, Xie JW, Lipner J, et al. Nanofiber Scaffolds with Gradations in Mineral Content for Mimicking the Tendon-to-Bone Insertion Site. Nano Letters, 2009, 9(7): 2763~2768
[15] Duan B, Wu LL, Yuan XY, et al. Hybrid nanofibrous membranes of PLGA/chitosan fabricated via an electrospinning array. Journal of Biomedical Materials Research Part A, 2007, 83A (3): 868~878
[16] Laschke MW, Strohe A, Scheuer C, et al. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering. Acta Biomaterialia, 2009, 5 (6): 1991~2001
[17] Zimmermann WH, Cesnjevar R. Cardiac Tissue Engineering: Implications for Pediatric Heart Surgery. Pediatr Cardiol, 2009, 30(5):716~723
[18] Yao L, O’brien N, Windebank A, et al. Orienting neurite growth in electrospun fibrous neural conduits. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B (2): 483~491
[19] Kikuchi K, Sumaru K, Edahiro JI, et al. Stepwise Assembly of Micropatterned Co-cultures Using Photoresponsive Culture Surfaces and Its Application to Hepatic Tissue Arrays. Biotechnology and Bioengineering, 2009, 103(3): 552~561
[20] Serra M, Brito C, Leite SB, et al. Stirred bioreactors for the expansion of adult pancreatic stem cells. Annals Anatomy, 2009, 191 (1): 104~115
[21] Stevens B, Yang YZ, Mohandas A, et al. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 85B(2): 573~582
[22] Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes. Expert Reviews of Medical Devices, 2006, 3(1):49~57
[23] Geiger M, Li LH, Friess W. Collagen sponges for bone regeneration with rhBMP-2.Advanced Drug Delivery Reviews, 2003, 55(12): 1613~1629
[24] Crane GM, Ishaug SL, Mikos AG. Bone tissue engineering, Nature Medicine, 1995, 1(12):1322~1324.
[25] Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials, 2003, 24 (13): 2133~2151
[26]姚康得,尹玉姬,组织工程相关生物材料,北京:化学工业出版社,2003.133~134
[27] Murugan R, Ramakrishna S. Development of nanocomposites for bone grafting. Composites Science and Technology, 2005, 65(15-16): 2385~2406
[28] Lowenstam HA, Weiner S. On biomineralization. New York:Oxford University Press; 1989.
[29] Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science, 2000, 289 (5484):1501~1504
[30] Salgado AJ, Coutinho OP, Reis RL. Bone Tissue Engineering: State of the Art and Future Trends. Macromolecular Bioscience, 2004, 4(8):743~765
[31] Maeda M, Hirose M, Ohgushi H, et al. In vitro mineralization by mesenchymal stem cells cultured on titanium scaffolds, Journal of Biochemistry, 2007, 141(5): 729~736
[32] Goodman SB, Ma T, Chiu R, et al. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials, 2006, 27 (36):6096~6101
[33] Vermes C, Chandrasekaran R, Jacobs JJ, et al. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. Journal of bone and joint surgery-American Volume, 2001, 83A (2):201~211
[34] Takei H, Pioletti DP, Kwon SY, et al. Combined effect of titanium particles and TNF-a on the production of IL-6 by osteoblast-like cells. Journal of Biomedical Materials Research, 2000, 52 (2):382~387
[35] Breme J, Zhou Y, Groh L. Development of a titanium alloy suitable for an optimized coating with hydroxyapatite. Biomaterials, 1995, 16(3):239~244
[36] Smith IO, Baumann MJ, McCabe LR. Electrostatic interactions as a predictor for osteoblast attachment to biomaterials. Journal of Biomedical Materials Research A, 2004, 70 (3):436~441
[37] Ducheyne P, Qiu Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials, 1999, 20(23-24):2287~2303
[38] Dieudonne SC, van den Dolder J, de Ruijter JE, et al. Osteoblast differentiation of bone marrow stromal cells cultured on silica gel and sol–gel-derived titania. Biomaterials, 2002, 23(14):3041~3051
[39] Hench LL. Bioceramics: from concept to clinic. Journal of the American Ceramic Society, 1991,74(7):1487~1510
[40] Ge ZG, Jin Z, Cao T. Manufacture of degradable polymeric scaffolds for bone regeneration. Biomedical Materials, 2008, 3(2): 02200
[41] Smith R. Biodegradable Polymers for Industrial Applications, 2005 (New York: CRC Press)
[42] Grieb TA, Forng RY, Stafford RE, et al. Effective use of optimized, high-dose (50 kGy) gamma irradiation for pathogen inactivation of human bone allografts. Biomaterials, 2005, 26(14):2033~2042
[43] Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials, 2000, 21(24): 2529~2543
[44] Lee CH, Singla A, Lee YY. Biomedical applications of collagen. International Journal of Pharmaceutics, 2001, 221(1-2):1~22
[45] Wang YW, Wu Q, Chen JC, et al. Evaluation of three-dimensional scaffolds made of blends of hydroxyapatite and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for bone reconstruction. Biomaterials, 2005, 26 (8): 899~904
[46] Turco G, Marsich E, Bellomo F, et al. Alginate/Hydroxyapatite Biocomposite for Bone Ingrowth: A Trabecular Structure With High and Isotropic Connectivity. Biomacromolecules, 2009, 10 (6): 1575~1583
[47] Nejati E, Firouzdor V, Eslaminejad MB, et al. Needle-like nano hydroxyapatite/poly(L-lactide acid) composite scaffold for bone tissue engineering application. Materials Science and Engineering C, 2009, 29 (3): 942~949
[48] Sawyer AA, Song SJ, Susanto E, et al. The stimulation of healing within a rat calvarial defect by mPCL–TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials, 2009, 30 (13): 2479~2488
[49] Lee SJ, Oh SH, Liu J, et al. The use of thermal treatments to enhance the mechanical properties of electrospun poly(ε-caprolactone) scaffolds. Biomaterials, 2008, 29(10): 1422~1430
[50] Leong KF, Cheah CM, Chua CK, Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials, 2003, 24 (13):2363~2378
[51] Mikos AG, Thorsen AJ, Czerwonka LA, et al. Preparation and characterization of poly(l-lactic acid) foams. Polymer, 1994, 35 (5):1068~1077
[52] Pamula E, FilováE, BaákováL, et al. Resorbable polymeric scaffolds for bone tissue engineering: The influence of their microstructure on the growth of human osteoblast-like MG 63 cells. Journal of Biomedical Materials Research Part A, 2009, 89A (2): 432~443
[53] Vaquette C, Frochot C, Rahouadj R. An innovative method to obtain porous PLLA scaffolds with highly spherical and interconnected pores. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 86B (1): 9~17
[54] Wu LB, Jing DY, Ding, JD. A“room-temperature”injection molding/particulate leaching approach for fabrication of biodegradable three-dimensional porous scaffolds. Biomaterials, 2006, 27(2): 185~191
[55] Seol YJ, Lee JY, Park YJ, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnology Letters, 2004, 26 (13): 1037~1041
[56] Goh YQ, Ooi CP. Fabrication and characterization of porous poly(L-lactide) scaffolds using solid-liquid phase separation. Journal of Materials Science-Materials in Medicine, 2008, 19(6): 2445~2452
[57] Ma PX, Zhang RY. Synthetic nano-scale fibrous extracellular matrix. Journal of Biomedical Materials Research, 1999, 46(1): 60~72
[58] Liu XH, Won YJ, Ma PX. Porogen-induced surface modification of nano-fibrous poly(L-lactic acid) scaffolds for tissue engineering. Biomaterials, 2006, 27 (21): 3980~3987
[59] Zhu XH, Lee LY, Jackson, JSH, et al. Characterization of porous poly(D,L-Lactic-co-glycolic acid) sponges fabricated by supercritical CO2 gas-foaming method as a scaffold for three-dimensional growth of hep3B cells. Biotechnology and Bioengineering, 2008, 100(5): 998~1009
[60] Yoon JJ, Kim JH, Park TG. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials, 2003, 24 (13): 2323~2329
[61] Jose MV, Thomas V, Dean DR, et al. Fabrication and characterization of aligned nanofibrous PLGA/Collagen blends as bone tissue scaffolds. Polymer, 2009, 50 (15): 3778 ~3785
[62] Zhong SP, Teo WE, Zhu X, et al. An aligned nanofibrous collagen scaffold by electrospinning and its effects on in vitro fibroblast culture. Journal of Biomedical Materials Research, Part A, 2006, 79(3):456~463
[63] Lee CH, Shin HJ, Cho IH, et al. Nanofiber alignment and direction of mechanical strain affect the ECM production of human ACL fibroblast. Biomaterials, 2005, 26(11):1261~1270
[64] Buchmeiser MR. Monolithic Biocompatible and Biodegradable Scaffolds for Tissue Engineering. Journal of Polymer Science Part A: Polymer Chemistry, 2009, 47(9): 2219-2227
[65] Shen F, Cui YL, Yang LF, et al. A study on the fabrication of porous chitosan/gelatin network scaffold for tissue engineering. Polymer International, 2000, 49(12):1596~1599
[66] Cima LG, Vacanti JP, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer substrate. Journal of Biomechanical Engineering, 1991, 113(2): 143~151
[67] Fierz FC, Beckmann F, Huser M, et al. The morphology of anisotropic 3D-printed hydroxyapatite scaffolds. Biomaterials, 2008, 29 (28): 3799~3806
[68] Leukers B, Gulkan H, Irsen SH, et al. Hydroxyapatite scaffolds for bone tissue engineering made by 3D printing. Journal of Materials Science: Materials in Medicine, 2005, 16 (12): 1121~1124
[69] Leukers B, Gulkan H, Irsen SH, et al. Biocompatibility of ceramic scaffolds for bone replacement made by 3D printing. Materialwissenschaft und werkstofftechnik, 2005, 36(12):781~787
[70] Seitz H, Rieder WG, Irsen S, et al. Three-dimensional printing of porous ceramic scaffolds for bone tissue engineering. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2005, 74B (2): 782~788
[71] Hutmacher DW, Schantz T, Zein I, et al. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. Journal of Biomedical Materials Research, 2001, 55(2): 203~216
[72] Tellis BC, Szivek JA, Bliss CL, et al. Trabecular scaffolds created using micro CT guided fused deposition modeling. Materials Science and Engineering C, 2008, 28(1): 171~178
[73] Rai B, Teoh SH, Hutmacher DW, et al. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials, 2005, 26(17): 3739~3748
[74] Zein I, Hutmacher DW, Tan KC, et al. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials, 2002, 23(4): 1169~1185
[75] Schantz JT, Brandwood A, Hutmacher DW, et al. Osteogenic differentiation of mesenchymal progenitor cells in computer designed fibrin-polymer-ceramic scaffolds manufactured by fused deposition modeling. Journal of Materials Science-Materials in Medicine, 2005, 16(9) 807~819
[76] Arcaute K, Ochoa L, Mann B, et al. Hydrogels in stereolithography. In: 16th Annual Solid Freeform Fabrication Symposium, Austin, TX, 2005. pp 434~445
[77] Melchels FPW, Feijen J, Grijpma DW. A poly(d,l-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials, 2009, 30(23-24):3801~3809
[78] Porter NL, Pilliar RM, Grynpas MD. Fabrication of porous calcium polyphosphate implants by solid freeform fabrication: A study of processing parameters and in vitro degradation characteristics. Journal of Biomedical Materials Research, 2001, 56(4):504~515
[79] Williams JM, Adewunmi A, Schek RM, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials, 2005, 26(23): 4817~4827
[80] Kanczler JM, Mirmalek-Sani SH, Hanley NA, et al. Biocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds. Acta Biomaterialia, 2009, 5(6): 2063~2071
[81] Simpson RL, Wiria FE, Amis AA, et al. Development of a 95/5poly (L-lactide-co-glycolide)/hydroxylapatite andβ-tricalcium phosphate scaffold as bone replacement material via selective laser sintering. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 84B(1): 17~25
[82] Zhou WY, Lee SH, Wang M, et al. Selective laser sintering of porous tissue engineering scaffolds from poly(L-lactide)/carbonated hydroxyapatite nanocomposite microspheres. Journal of Materials Science-Materials In Medicine, 2008, 19(7):2535~2540
[83] Yang YF, Zhao YH, Tang GW, et al. In vitro degradation of porous poly(L-lactide-co-glycolide)/beta-tricalcium phosphate (PLGA/beta-TCP) scaffolds under dynamic and static conditions. Polymer Degradation and Stability, 2008, 93(10): 1838~1845
[84] Li XR, Zhang H, Li H, et al. Self-accelerated biodegradation of electrospun poly(ethylene glycol)–poly(l-lactide) membranes by loading proteinase K. Polymer Degradation and Stability, 2008, 93(3): 618~626
[85] Cai Q, Shi GX, Bei JZ. Enzymatic degradation behavior and mechanism of Poly(lactide-co-glycolide) foams by trypsin. Biomaterials, 2003, 24(4):629~638
[86] Wu LB, Ding DJ. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials, 2004, 25(27): 5821~5830
[87] Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials, 1995, 16(15): 1123~1130
[88] Wu LB, Ding JD. Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Journal of Biomedical Materials Research Part A 2005, 75A(4): 767~777
[89] Thomson RC, Mikos AG. Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials, 1999, 20(21): 2007~2018
[90] Deng M, Uhrich KE. Effects of in vitro degradation on properties of poly(DL-lactide-co-glycolide) pertinent to its biological performance. Journal of Materials Science-Materials In Medicine, 2002, 13(11): 1091~1096
[91] Chantal E, Davies JE. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials, 1999, 20(13): 1177~1185
[92] Agrawal CM, McKinney JS, Lanctot, D. Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials 2000, 21(23): 2443~2452
[93] Fan YB, Li P, Zeng L, et al. Effects of mechanical load on the degradation of poly(d,l-lactic acid) foam. Polymer Degradation and Stability, 2008, 93(3):677~683
[94] Yang F, Cui WJ, Xiong Z, et al. Poly(L,L-lactide-co-glycolide)/tricalcium phosphate composite scaffold and its various changes duringdegradation in vitro. Polymer Degradation and Stability, 2006, 91(12):3065~3073
[95] Loher S, Reboul V, Brunner TJ, et al. Improved degradation and bioactivity of amorphous aerosol derived trical-cium phosphate nanoparticles in poly(lactide-co-glycolide). Nanotechnology, 2006, 17(8):2054~2061
[96] Ara M, Watanabe M, Imai Y. Effect of blending calcium compounds on hydrolytic degradation of poly(DL-lactic acid-co-glycolic acide). Biomaterials, 2002, 23(12): 2479~2483
[97] Park K, Park JS, Woo DG, et al. The use of chondrogenic differentiation drugs to induce stem cell differentiation using double bead microsphere structure. Biomaterials, 2008, 29(16): 2490~2500
[98] Kretlow JD, Mikos AG. From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. Aiche Journal, 2008, 54(12): 3048~3067
[99] Carano RAD, Filvaroff EH. Angiogenesis and bone repair. Drug Discovery Today, 2003, 8(21) 980~989
[100] El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Review of Medical Devices, 2005, 2(1): 87~101
[101] Lee SH, Shin HS. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Advanced Drug Delivery Reviews, 2007, 59(4-5):339~359
[102] Rose FRAJ, Hou QP, Oreffo ROC. Delivery systems for bone growth factors - the new players in skeletal regeneration. Journal of Pharmacy and Pharmacology, 2004, 56(4):415~427
[103] Cartmell S. Controlled Release Scaffolds for Bone Tissue Engineering. Journal of Pharmaceutical Sciences, 2009, 98(2):430~441
[104] Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. Journal of Cellular Biochemistry, 2004, 93(1):93~103
[105] Holland TA, Mikos AG. Review: Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Tissue Engineering I :Scaffold Systems for Tissue Engineering, 2006, 102: 161~185
[106] Chen FM, Zhao YM, Wu H, et al. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. Journal of Controlled Release, 2006, 114(2): 209~222
[107] Meinel L, Zoidis E, Zapf J, et al. Localized insulin-like growth factor I delivery to enhance new bone formation, Bone, 2003, 33(4): 660~672
[108] Uebersax L, Merkle HP, Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. Journal of Controlled Release, 2008, 127(1): 12~21
[109] Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone, 2002, 30(3): 472~477
[110] Orlandini M, Spreafico A, Bardelli M, et al. Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation, Journal of Biological Chemistry, 2006, 281(26): 17961~17967
[111] Klopper J, Lindenmaier W, Fiedler U, et al. High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells. Microvascular Research, 2008, 75 (1): 83~90
[112] Kim H, Kim HW, Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials, 2003, 24(25):4671~4679
[113]温学红,郭若霖,程瑞芳等,BMP-2和地塞米松对成人成骨细胞增殖和分化的影响.临床检验杂志, 2005, 23(11):34~37
[114] Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid,β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials, 2000, 21(11): 1095~1102
[115] Otsuka E, Yamaguchi A, Hirose S, et al. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid, American Journal of Physiology-Cell Physiology, 1999,277(1): C132~C138
[116] Anitua E, Sanchez M, Orive G, et al. Delivering growth factors for therapeutics. Trends in Pharmacological Science, 2008, 29(1):37~41
[117] Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharmaceutical Research, 2003, 20(8):1103~1112
[118] Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharmaceutical Research, 2000, 17(5):497~504
[119] Golden JD, Jones AL, Bucholz RW, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. Journal of Bone and Joint Surgery-American Volume, 2008, 90A(5):1168~1169
[120] Zhang SF, Uludag H. Nanoparticulate Systems for Growth Factor Delivery. Pharmaceutical Research, 2009, 26(7): 1561~1580
[121] Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of Controlled Release, 2005, 102(2): 313~332
[122] Sah H, Lee B. Development of new microencapsulation techniques useful for the preparation of PLGA microspheres. Macromolecular rapid Communications, 2006, 27(21): 1845~1851
[123] Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Advanced Drug Delivery Reviews, 2003, 55(3): 315~328
[124] Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Advanced Drug Delivery Reviews, 2007, 59(4-5): 249~262
[125] Zhang Y, Zhang MQ. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. Journal of Biomedical Materials Research, 2002, 62(3):378~386
[126] Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(ε-caprolactone) and hydroxyapatite hybrid coatings. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 2004, 70B(2): 240~249
[127] Zhang LF, Yang DJ, Chen HC, et al. An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture. International Journal of Pharmaceutics, 2008, 353(1-2):74~87
[128] Wei GB, Jin QM, Giannobile WV, et al. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. Journal of Controlled Release, 2006, 112(1): 103~110
[129] Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science, 2000, 289(5484): 1508~1514
[130] Patel ZS, Ueda H, Yamamoto M, et al. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharmaceutical Research, 2008, 25(10): 2370~2378
[131] Langer R. Drug delivery systems. MRS Bull XVI, 1991, (9): 47~49
[132] Chellat F, Tabrizian M, Dumitriu S, et al. Study of biodegradation behavior of chitosan-xanthan microspheres in simulated physiological media. Journal of Biomedical Materials Research, 2000, 53(5): 592~599.
[133] Silver GA, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 1. Basic concepts. Journal of Tissue Engineering and Regenerative Medicine, 2007, 1(1): 4~24
[134] Grassi M, Colombo I, Lapasin R. Experimental determination of the theophylline diffusion coefficient in swollen sodium-alginate membranes. Journal of Controlled Release, 2001, 76(1-2): 93~105
[135] Berkland C, King M, Cox A, et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. Journal of Controlled Release, 2002, 82(1): 137~147
[136] Simmons CA, Alsberg E, Hsiong S, et al. Dual growth factor delivery and controlled scaffold degrad,ation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone, 2004, 35(2): 562~569
[137] Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair. International Journal of Developmental Biology, 1993, 37(4): 573~579
[138] Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. Journal of Cellular Biochemistry, 2003, 88(5): 873~884
[139] Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials, 2004, 25(4): 677~685
[140] Bostrom MPG, Lane JM, Berberian WS, et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. Journal of Orthopaedic Research, 1995, 13(3):357~367
[141] Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair, International Journal of Developmental Biology, 1993, 37(4): 573~579
[142] Yu Y, Yang JL, Chapman-Sheath PJ, et al. TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing. Journal of Biomedical Materials Research, 2002, 60(3): 392~397
[143] Jaklenec A, Hinckfuss A, Bilgen B, et al. Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds. Biomaterials, 2008, 29(10): 1518~1525
[144] Yeh LCC, Adamo ML, Olson MS, et al. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology, 1997, 138(10):4181~4190
[145] Yeh LCC, Zavala MC, Lee JC. Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. Journal of Cellular Physiology, 2002, 190(3): 322~331
[146] Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients withperiodontal disease. Journal of Periodontology, 1997, 68(12):1186~1193
[147] Takita H, Tsuruga E, Ono I, et al. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. European Journal of Oral Sciences, 1997, 105 (6):588~592
[148] Sohier J, Vlugt TJH, Cabrol N, et al. Dual release of proteins from porous polymeric scaffolds. Journal of Controlled Release, 2006, 111(1-2): 95~106
[149] Konishi M, Tabata Y, Kariya M, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. Journal of Controlled Release, 2005, 103(1):7~19
[150] Riley CM, Fuegy PW, Firpo MA, et al. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials, 2006, 27(35): 5935~5943
[151] Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials, 2008, 29(31): 4195~4204
[152] Tanaka SM, Li JL; Duncan RL, et al. Effects of broad frequency vibration on cultured osteoblasts. Journal of Biomechanics, 2003, 36(1): 73~80
[153] Yang YF, Zhao J, Zhao YH, et al. Formation of porous PLGA scaffolds by a combining method of thermally induced phase separation and porogen leaching. Journal of Applied Polymer Science, 2008, 109(2): 1232~1241
[154] Oh SH, Kang SG, Lee JH. Degradation behavior of hydrophilized PLGA scaffolds prepared by melt-molding particulate-leaching method: Comparison with control hydrophobic one. Journal of Materials Science-Materials in Medicine, 2006, 17(2):131~137
[155] Shi GX, Cai Q, Wang CY, et al. Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polymers for Advanced Technologies, 2002, 13(3-4): 227~232
[156] Hou QP, Grijpma DW, Feijen J. Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials, 2003, 24(11): 1937~1947
[157] Hua FJ, Kim GE, Lee JD, et al. Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid-liquid phase separation of a PLLA-dioxane-water system. Journal of Biomedical Materials Research, 2002, 63(2): 161~167
[158] Zhang R, Weng WJ, Du PY, et al. Effect of Pluronic F127 on the pore structure of macrocellular biodegradable polylactide foams. Polymers for Advanced Technologies, 2004, 15(7): 425~430
[159] Zhang JC, Wu LB, Jing DY, et al. A comparative study of porous scaffolds withcubic and spherical macropores. Polymer, 2005, 46(13):4979~4985
[160]孙蕊,张丽芳,杜建等.聚乳酸/β-磷酸三钙多孔复合支架的制备及性能研究.合成化学, 2004, 12(6): 536~539
[161] Li HY, Chang J. pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA. Composites Science and Technology, 2005, 65(14): 2226~2232
[162] Chen VJ, Ma PX. The effect of surface area on the degradation rate of nano-fibrous poly(l-lactic acid) foams. Biomaterials, 2006, 27(20): 3708~3715
[163] Lu L, Garcia CA, Mikos AG. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. Journal of Biomedical Materials Reserch, 1999, 46(2): 236~244
[164] Fernandes ALP, Morais WA, Santos AIB, et al. The influence of oxidative degradation on the preparation of chitosan nanoparticles. Colloid and Polymer Science, 2005, 284(1):1~9
[165] Fan YJ, Nishida H, Shirai Y, et al. Thermal stability of poly (L-lactide): influence of end protection by acetyl group. Polymer Degradation and Stability, 2004, 84(1):143~149
[166] Kaczmarek H, Bajer K, Galka P, et al. Photodegradation studies of novel biodegradable blends based on poly(ethylene oxide) and pectin. Polymer Degradation and Stability, 2007, 92(11):2058~2069
[167] Akyuz A, Catalgil-Giz H, Giz AT. Kinetics of ultrasonic polymer degradation: Comparison of theoretical models with on-line data. Macromolecular Chemistry Physics, 2008, 209(8): 801~809
[168] Roy PK, Surekha P, Rajagopal C, et al. Studies on the photo-oxidative degradation of LDPE films in the presence of oxidised polyethylene. Polymer Degradation and Stability, 2007, 92(6):1151~1160
[169] Kaczmarek H, Podgorski A. The effect of UV-irradiation on poly(vinyl alcohol) composites with montmorillonite. Journal of Photochemistry Photobiology A-Chemistry, 2007, 191: 209~215
[170] Loo JSC, Ooi CP, Boey FYC. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. Biomaterials, 2005, 26(12): 1359~1367
[171] Tanaka SM, Li JL, Duncan RL, et al, Effects of broad frequency vibration on cultured osteoblasts. Journal of Biomechanics, 2003, 36(1):73~80
[172]周茂生,齐新生.成骨细胞和支架材料复合的研究进展.国外医学生物医学工程分册,2005,28(4):226~229
[173]鲜苏琴,柴枫,赵铱民等.成骨细胞在快速成型技术构建的骨支架材料中粘附的实验研究.华西口腔医学杂志,2004,22(3):248~251
[174]邵英,张舵,荣莉等.聚L-乳酸/聚L-乳酸接枝纳米羟基磷灰石复合材料对成骨细胞黏附和增殖能力的影响.中国组织工程研究与临床康, 2009, 13(34): 6617~6621
[175] Douglas T, Pamula E, Hauk D, et al. Porous polymer/hydroxyapatite scaffolds: characterization and biocompatibility investigations. Journal of Materials Science-Materials in Medicine, 2009, 20(9): 1909~1915
[176] Rohanizadeh R, Swain MV, Mason RS. Gelatin sponges (Gelfoam (R)) as a scaffold for osteoblasts. Journal of Materials Science-Materials in Medicine, 2008, 19(3): 1173~1182
[177] Qu X, Cui WJ, Yang F, et al. The effect of oxygen plasma pretreatment and incubation in modified simulated body fluids on the formation of bone-like apatite on poly(lactide-co-glycolide) (70/30). Biomaterials, 2007, 28(1): 9~18
[178] Kim HW, Kim HE, Salih V, et al. Dissolution control and cellular responses of calcium phosphate coatings on zirconia porous scaffold. Journal of Biomedical Materials Research, 2004, 68A(3): 522~530
[179] Rosso F, Giordano A, Barbarisi M, et al. From cell-ECM interactions to tissue engineering. Journal of Cellular Physiology, 2004, 199(2): 174~180
[180] Teng SH, Lee EJ, Wang P, et al. Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B(1): 275~282
[181] Niu XF, Feng QL, Wang MB, et al. In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide. Polymer Degradation and Stability, 2009, 94(2): 176~182
[182] Yang YY, Chung TS, Ng NP, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 2001, 22(3): 231~241
[183] Soriano I , Llabres M, Evora C. Release control of albumin from polylactic acid microspheres. International Journal of Pharmaceutics, 1995, 125(2): 223~230
[184] Bezemer JM, Grijpma DW, Dijkstra PJ, et al. Control of protein delivery from amphiphilic poly(ether ester) multiblock copolymers by varying their water content using emulsification techniques. Journal of Controlled Release, 2000, 66(2-3): 307~320
[185] Rafati H, Coombes AGA, Adler J, et al. Protein-loaded poly(DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. Journal of Controlled Release, 1997, 43(1): 89~102
[186] Whang K, Goldstick TK, Healy KE. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials, 2000, 21(14): 2545~2551
[187]Wei GB, Pettway GJ, McCauley LK, et al. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials, 2004, 25(2):345~352
[188] Kim JH, Bae YH. Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/poly(α-ester) multiblock copolymer. European Journal of Pharmaceutical Sciences, 2004, 23(3): 245~251
[189] Lee KY, Peters MC, Mooney DJ. Controlled drug delivery from polymers by mechanical signals. Advanced Materials, 2001, 13(11): 837~839
[190] Chen LB, Jiang QB, Lu WX. Production of Redispersible Powdered by Spray-Drying Process. Paint&Coatings Industry. 2008, 38(2): 30-35
[191] Lin XN, Zhou RM, Qiao Y, et al. Poly(ethylene glycol)/poly(ethyl cyanoacrylate) amphiphilic triblock copolymer nanoparticles as delivery vehicles for dexamethasone. Polymer Chemistry, 2008, 46(23): 7809-7815
[192] Corre PL, Guevello PL, Gajan V, et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. International Journal of Pharmaceutics, 1994, 107(1): 41-49
[193] Zhao L, He C G, Gao Y J. Study on Influence of Copolymer Compositions of PLGA on Properties of Scaffolds. China Biotechnology, 2008, 28(5): 22-28
[194] Hickey T, Kreutzer D, Burgess D J, et al. Dexamethasone/PLGA microsphere for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials, 2002, 23(7): 1649-1656
[2] Langer R, Vacanti JP. Tissue engineering. Science, 1993, 260(5110): 920~926
[3] Hench LL. Biomaterials: a forecast for the future. Biomaterials, 1998, 19 (16): 1419~1423
[4] Shin HS, Jo SB, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials, 2003, 24 (24): 4353~4364
[5] Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet, 1999, 354(suppl I):32~34
[6] Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chemical Reviews, 2001, 101(7):1869~1879
[7] Putnam AJ, Mooney DJ. Tissue engineering using synthetic extracellular matrices. Nature Medicine, 1996, 2(7):824~826
[8] Marler JJ, Upton J, Langer R, et al. Transplantation of cells in matrices for tissue engineering. Advanced Drug Delivery Reviews, 1998, 33(1-2):165-182
[9] Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends In Biotechnology, 1998, 16(5):224~230
[10] Agrawa CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. Journal of Biomedical Materials Research, 2001, 55(2):141~150
[11] Quaglia F. Bioinspired tissue engineering: The great promise of protein delivery technologies. International Journal of Pharmaceutics, 2008, 364(2) 281~297
[12] Al-Munajjed AA, Plunkett NA, Gleeson JP, et al. Development of a biomimetic collagen-hydroxyapatite scaffold for bone tissue engineering using a SBF immersion technique. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B(2): 584~591
[13] Ye C, Hu P, Ma MX, et al. PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials, 2009, 30(26): 4401~4406
[14] Li XR, Xie JW, Lipner J, et al. Nanofiber Scaffolds with Gradations in Mineral Content for Mimicking the Tendon-to-Bone Insertion Site. Nano Letters, 2009, 9(7): 2763~2768
[15] Duan B, Wu LL, Yuan XY, et al. Hybrid nanofibrous membranes of PLGA/chitosan fabricated via an electrospinning array. Journal of Biomedical Materials Research Part A, 2007, 83A (3): 868~878
[16] Laschke MW, Strohe A, Scheuer C, et al. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering. Acta Biomaterialia, 2009, 5 (6): 1991~2001
[17] Zimmermann WH, Cesnjevar R. Cardiac Tissue Engineering: Implications for Pediatric Heart Surgery. Pediatr Cardiol, 2009, 30(5):716~723
[18] Yao L, O’brien N, Windebank A, et al. Orienting neurite growth in electrospun fibrous neural conduits. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B (2): 483~491
[19] Kikuchi K, Sumaru K, Edahiro JI, et al. Stepwise Assembly of Micropatterned Co-cultures Using Photoresponsive Culture Surfaces and Its Application to Hepatic Tissue Arrays. Biotechnology and Bioengineering, 2009, 103(3): 552~561
[20] Serra M, Brito C, Leite SB, et al. Stirred bioreactors for the expansion of adult pancreatic stem cells. Annals Anatomy, 2009, 191 (1): 104~115
[21] Stevens B, Yang YZ, Mohandas A, et al. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 85B(2): 573~582
[22] Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes. Expert Reviews of Medical Devices, 2006, 3(1):49~57
[23] Geiger M, Li LH, Friess W. Collagen sponges for bone regeneration with rhBMP-2.Advanced Drug Delivery Reviews, 2003, 55(12): 1613~1629
[24] Crane GM, Ishaug SL, Mikos AG. Bone tissue engineering, Nature Medicine, 1995, 1(12):1322~1324.
[25] Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials, 2003, 24 (13): 2133~2151
[26]姚康得,尹玉姬,组织工程相关生物材料,北京:化学工业出版社,2003.133~134
[27] Murugan R, Ramakrishna S. Development of nanocomposites for bone grafting. Composites Science and Technology, 2005, 65(15-16): 2385~2406
[28] Lowenstam HA, Weiner S. On biomineralization. New York:Oxford University Press; 1989.
[29] Ducy P, Schinke T, Karsenty G. The osteoblast: A sophisticated fibroblast under central surveillance. Science, 2000, 289 (5484):1501~1504
[30] Salgado AJ, Coutinho OP, Reis RL. Bone Tissue Engineering: State of the Art and Future Trends. Macromolecular Bioscience, 2004, 4(8):743~765
[31] Maeda M, Hirose M, Ohgushi H, et al. In vitro mineralization by mesenchymal stem cells cultured on titanium scaffolds, Journal of Biochemistry, 2007, 141(5): 729~736
[32] Goodman SB, Ma T, Chiu R, et al. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials, 2006, 27 (36):6096~6101
[33] Vermes C, Chandrasekaran R, Jacobs JJ, et al. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. Journal of bone and joint surgery-American Volume, 2001, 83A (2):201~211
[34] Takei H, Pioletti DP, Kwon SY, et al. Combined effect of titanium particles and TNF-a on the production of IL-6 by osteoblast-like cells. Journal of Biomedical Materials Research, 2000, 52 (2):382~387
[35] Breme J, Zhou Y, Groh L. Development of a titanium alloy suitable for an optimized coating with hydroxyapatite. Biomaterials, 1995, 16(3):239~244
[36] Smith IO, Baumann MJ, McCabe LR. Electrostatic interactions as a predictor for osteoblast attachment to biomaterials. Journal of Biomedical Materials Research A, 2004, 70 (3):436~441
[37] Ducheyne P, Qiu Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials, 1999, 20(23-24):2287~2303
[38] Dieudonne SC, van den Dolder J, de Ruijter JE, et al. Osteoblast differentiation of bone marrow stromal cells cultured on silica gel and sol–gel-derived titania. Biomaterials, 2002, 23(14):3041~3051
[39] Hench LL. Bioceramics: from concept to clinic. Journal of the American Ceramic Society, 1991,74(7):1487~1510
[40] Ge ZG, Jin Z, Cao T. Manufacture of degradable polymeric scaffolds for bone regeneration. Biomedical Materials, 2008, 3(2): 02200
[41] Smith R. Biodegradable Polymers for Industrial Applications, 2005 (New York: CRC Press)
[42] Grieb TA, Forng RY, Stafford RE, et al. Effective use of optimized, high-dose (50 kGy) gamma irradiation for pathogen inactivation of human bone allografts. Biomaterials, 2005, 26(14):2033~2042
[43] Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials, 2000, 21(24): 2529~2543
[44] Lee CH, Singla A, Lee YY. Biomedical applications of collagen. International Journal of Pharmaceutics, 2001, 221(1-2):1~22
[45] Wang YW, Wu Q, Chen JC, et al. Evaluation of three-dimensional scaffolds made of blends of hydroxyapatite and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for bone reconstruction. Biomaterials, 2005, 26 (8): 899~904
[46] Turco G, Marsich E, Bellomo F, et al. Alginate/Hydroxyapatite Biocomposite for Bone Ingrowth: A Trabecular Structure With High and Isotropic Connectivity. Biomacromolecules, 2009, 10 (6): 1575~1583
[47] Nejati E, Firouzdor V, Eslaminejad MB, et al. Needle-like nano hydroxyapatite/poly(L-lactide acid) composite scaffold for bone tissue engineering application. Materials Science and Engineering C, 2009, 29 (3): 942~949
[48] Sawyer AA, Song SJ, Susanto E, et al. The stimulation of healing within a rat calvarial defect by mPCL–TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials, 2009, 30 (13): 2479~2488
[49] Lee SJ, Oh SH, Liu J, et al. The use of thermal treatments to enhance the mechanical properties of electrospun poly(ε-caprolactone) scaffolds. Biomaterials, 2008, 29(10): 1422~1430
[50] Leong KF, Cheah CM, Chua CK, Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials, 2003, 24 (13):2363~2378
[51] Mikos AG, Thorsen AJ, Czerwonka LA, et al. Preparation and characterization of poly(l-lactic acid) foams. Polymer, 1994, 35 (5):1068~1077
[52] Pamula E, FilováE, BaákováL, et al. Resorbable polymeric scaffolds for bone tissue engineering: The influence of their microstructure on the growth of human osteoblast-like MG 63 cells. Journal of Biomedical Materials Research Part A, 2009, 89A (2): 432~443
[53] Vaquette C, Frochot C, Rahouadj R. An innovative method to obtain porous PLLA scaffolds with highly spherical and interconnected pores. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 86B (1): 9~17
[54] Wu LB, Jing DY, Ding, JD. A“room-temperature”injection molding/particulate leaching approach for fabrication of biodegradable three-dimensional porous scaffolds. Biomaterials, 2006, 27(2): 185~191
[55] Seol YJ, Lee JY, Park YJ, et al. Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnology Letters, 2004, 26 (13): 1037~1041
[56] Goh YQ, Ooi CP. Fabrication and characterization of porous poly(L-lactide) scaffolds using solid-liquid phase separation. Journal of Materials Science-Materials in Medicine, 2008, 19(6): 2445~2452
[57] Ma PX, Zhang RY. Synthetic nano-scale fibrous extracellular matrix. Journal of Biomedical Materials Research, 1999, 46(1): 60~72
[58] Liu XH, Won YJ, Ma PX. Porogen-induced surface modification of nano-fibrous poly(L-lactic acid) scaffolds for tissue engineering. Biomaterials, 2006, 27 (21): 3980~3987
[59] Zhu XH, Lee LY, Jackson, JSH, et al. Characterization of porous poly(D,L-Lactic-co-glycolic acid) sponges fabricated by supercritical CO2 gas-foaming method as a scaffold for three-dimensional growth of hep3B cells. Biotechnology and Bioengineering, 2008, 100(5): 998~1009
[60] Yoon JJ, Kim JH, Park TG. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials, 2003, 24 (13): 2323~2329
[61] Jose MV, Thomas V, Dean DR, et al. Fabrication and characterization of aligned nanofibrous PLGA/Collagen blends as bone tissue scaffolds. Polymer, 2009, 50 (15): 3778 ~3785
[62] Zhong SP, Teo WE, Zhu X, et al. An aligned nanofibrous collagen scaffold by electrospinning and its effects on in vitro fibroblast culture. Journal of Biomedical Materials Research, Part A, 2006, 79(3):456~463
[63] Lee CH, Shin HJ, Cho IH, et al. Nanofiber alignment and direction of mechanical strain affect the ECM production of human ACL fibroblast. Biomaterials, 2005, 26(11):1261~1270
[64] Buchmeiser MR. Monolithic Biocompatible and Biodegradable Scaffolds for Tissue Engineering. Journal of Polymer Science Part A: Polymer Chemistry, 2009, 47(9): 2219-2227
[65] Shen F, Cui YL, Yang LF, et al. A study on the fabrication of porous chitosan/gelatin network scaffold for tissue engineering. Polymer International, 2000, 49(12):1596~1599
[66] Cima LG, Vacanti JP, Vacanti C, et al. Tissue engineering by cell transplantation using degradable polymer substrate. Journal of Biomechanical Engineering, 1991, 113(2): 143~151
[67] Fierz FC, Beckmann F, Huser M, et al. The morphology of anisotropic 3D-printed hydroxyapatite scaffolds. Biomaterials, 2008, 29 (28): 3799~3806
[68] Leukers B, Gulkan H, Irsen SH, et al. Hydroxyapatite scaffolds for bone tissue engineering made by 3D printing. Journal of Materials Science: Materials in Medicine, 2005, 16 (12): 1121~1124
[69] Leukers B, Gulkan H, Irsen SH, et al. Biocompatibility of ceramic scaffolds for bone replacement made by 3D printing. Materialwissenschaft und werkstofftechnik, 2005, 36(12):781~787
[70] Seitz H, Rieder WG, Irsen S, et al. Three-dimensional printing of porous ceramic scaffolds for bone tissue engineering. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2005, 74B (2): 782~788
[71] Hutmacher DW, Schantz T, Zein I, et al. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. Journal of Biomedical Materials Research, 2001, 55(2): 203~216
[72] Tellis BC, Szivek JA, Bliss CL, et al. Trabecular scaffolds created using micro CT guided fused deposition modeling. Materials Science and Engineering C, 2008, 28(1): 171~178
[73] Rai B, Teoh SH, Hutmacher DW, et al. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials, 2005, 26(17): 3739~3748
[74] Zein I, Hutmacher DW, Tan KC, et al. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials, 2002, 23(4): 1169~1185
[75] Schantz JT, Brandwood A, Hutmacher DW, et al. Osteogenic differentiation of mesenchymal progenitor cells in computer designed fibrin-polymer-ceramic scaffolds manufactured by fused deposition modeling. Journal of Materials Science-Materials in Medicine, 2005, 16(9) 807~819
[76] Arcaute K, Ochoa L, Mann B, et al. Hydrogels in stereolithography. In: 16th Annual Solid Freeform Fabrication Symposium, Austin, TX, 2005. pp 434~445
[77] Melchels FPW, Feijen J, Grijpma DW. A poly(d,l-lactide) resin for the preparation of tissue engineering scaffolds by stereolithography. Biomaterials, 2009, 30(23-24):3801~3809
[78] Porter NL, Pilliar RM, Grynpas MD. Fabrication of porous calcium polyphosphate implants by solid freeform fabrication: A study of processing parameters and in vitro degradation characteristics. Journal of Biomedical Materials Research, 2001, 56(4):504~515
[79] Williams JM, Adewunmi A, Schek RM, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials, 2005, 26(23): 4817~4827
[80] Kanczler JM, Mirmalek-Sani SH, Hanley NA, et al. Biocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds. Acta Biomaterialia, 2009, 5(6): 2063~2071
[81] Simpson RL, Wiria FE, Amis AA, et al. Development of a 95/5poly (L-lactide-co-glycolide)/hydroxylapatite andβ-tricalcium phosphate scaffold as bone replacement material via selective laser sintering. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2008, 84B(1): 17~25
[82] Zhou WY, Lee SH, Wang M, et al. Selective laser sintering of porous tissue engineering scaffolds from poly(L-lactide)/carbonated hydroxyapatite nanocomposite microspheres. Journal of Materials Science-Materials In Medicine, 2008, 19(7):2535~2540
[83] Yang YF, Zhao YH, Tang GW, et al. In vitro degradation of porous poly(L-lactide-co-glycolide)/beta-tricalcium phosphate (PLGA/beta-TCP) scaffolds under dynamic and static conditions. Polymer Degradation and Stability, 2008, 93(10): 1838~1845
[84] Li XR, Zhang H, Li H, et al. Self-accelerated biodegradation of electrospun poly(ethylene glycol)–poly(l-lactide) membranes by loading proteinase K. Polymer Degradation and Stability, 2008, 93(3): 618~626
[85] Cai Q, Shi GX, Bei JZ. Enzymatic degradation behavior and mechanism of Poly(lactide-co-glycolide) foams by trypsin. Biomaterials, 2003, 24(4):629~638
[86] Wu LB, Ding DJ. In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials, 2004, 25(27): 5821~5830
[87] Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials, 1995, 16(15): 1123~1130
[88] Wu LB, Ding JD. Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Journal of Biomedical Materials Research Part A 2005, 75A(4): 767~777
[89] Thomson RC, Mikos AG. Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials, 1999, 20(21): 2007~2018
[90] Deng M, Uhrich KE. Effects of in vitro degradation on properties of poly(DL-lactide-co-glycolide) pertinent to its biological performance. Journal of Materials Science-Materials In Medicine, 2002, 13(11): 1091~1096
[91] Chantal E, Davies JE. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials, 1999, 20(13): 1177~1185
[92] Agrawal CM, McKinney JS, Lanctot, D. Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials 2000, 21(23): 2443~2452
[93] Fan YB, Li P, Zeng L, et al. Effects of mechanical load on the degradation of poly(d,l-lactic acid) foam. Polymer Degradation and Stability, 2008, 93(3):677~683
[94] Yang F, Cui WJ, Xiong Z, et al. Poly(L,L-lactide-co-glycolide)/tricalcium phosphate composite scaffold and its various changes duringdegradation in vitro. Polymer Degradation and Stability, 2006, 91(12):3065~3073
[95] Loher S, Reboul V, Brunner TJ, et al. Improved degradation and bioactivity of amorphous aerosol derived trical-cium phosphate nanoparticles in poly(lactide-co-glycolide). Nanotechnology, 2006, 17(8):2054~2061
[96] Ara M, Watanabe M, Imai Y. Effect of blending calcium compounds on hydrolytic degradation of poly(DL-lactic acid-co-glycolic acide). Biomaterials, 2002, 23(12): 2479~2483
[97] Park K, Park JS, Woo DG, et al. The use of chondrogenic differentiation drugs to induce stem cell differentiation using double bead microsphere structure. Biomaterials, 2008, 29(16): 2490~2500
[98] Kretlow JD, Mikos AG. From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. Aiche Journal, 2008, 54(12): 3048~3067
[99] Carano RAD, Filvaroff EH. Angiogenesis and bone repair. Drug Discovery Today, 2003, 8(21) 980~989
[100] El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Review of Medical Devices, 2005, 2(1): 87~101
[101] Lee SH, Shin HS. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Advanced Drug Delivery Reviews, 2007, 59(4-5):339~359
[102] Rose FRAJ, Hou QP, Oreffo ROC. Delivery systems for bone growth factors - the new players in skeletal regeneration. Journal of Pharmacy and Pharmacology, 2004, 56(4):415~427
[103] Cartmell S. Controlled Release Scaffolds for Bone Tissue Engineering. Journal of Pharmaceutical Sciences, 2009, 98(2):430~441
[104] Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. Journal of Cellular Biochemistry, 2004, 93(1):93~103
[105] Holland TA, Mikos AG. Review: Biodegradable polymeric scaffolds. Improvements in bone tissue engineering through controlled drug delivery. Tissue Engineering I :Scaffold Systems for Tissue Engineering, 2006, 102: 161~185
[106] Chen FM, Zhao YM, Wu H, et al. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. Journal of Controlled Release, 2006, 114(2): 209~222
[107] Meinel L, Zoidis E, Zapf J, et al. Localized insulin-like growth factor I delivery to enhance new bone formation, Bone, 2003, 33(4): 660~672
[108] Uebersax L, Merkle HP, Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. Journal of Controlled Release, 2008, 127(1): 12~21
[109] Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone, 2002, 30(3): 472~477
[110] Orlandini M, Spreafico A, Bardelli M, et al. Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation, Journal of Biological Chemistry, 2006, 281(26): 17961~17967
[111] Klopper J, Lindenmaier W, Fiedler U, et al. High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells. Microvascular Research, 2008, 75 (1): 83~90
[112] Kim H, Kim HW, Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials, 2003, 24(25):4671~4679
[113]温学红,郭若霖,程瑞芳等,BMP-2和地塞米松对成人成骨细胞增殖和分化的影响.临床检验杂志, 2005, 23(11):34~37
[114] Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid,β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials, 2000, 21(11): 1095~1102
[115] Otsuka E, Yamaguchi A, Hirose S, et al. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid, American Journal of Physiology-Cell Physiology, 1999,277(1): C132~C138
[116] Anitua E, Sanchez M, Orive G, et al. Delivering growth factors for therapeutics. Trends in Pharmacological Science, 2008, 29(1):37~41
[117] Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharmaceutical Research, 2003, 20(8):1103~1112
[118] Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharmaceutical Research, 2000, 17(5):497~504
[119] Golden JD, Jones AL, Bucholz RW, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. Journal of Bone and Joint Surgery-American Volume, 2008, 90A(5):1168~1169
[120] Zhang SF, Uludag H. Nanoparticulate Systems for Growth Factor Delivery. Pharmaceutical Research, 2009, 26(7): 1561~1580
[121] Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of Controlled Release, 2005, 102(2): 313~332
[122] Sah H, Lee B. Development of new microencapsulation techniques useful for the preparation of PLGA microspheres. Macromolecular rapid Communications, 2006, 27(21): 1845~1851
[123] Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Advanced Drug Delivery Reviews, 2003, 55(3): 315~328
[124] Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Advanced Drug Delivery Reviews, 2007, 59(4-5): 249~262
[125] Zhang Y, Zhang MQ. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. Journal of Biomedical Materials Research, 2002, 62(3):378~386
[126] Kim HW, Knowles JC, Kim HE. Development of hydroxyapatite bone scaffold for controlled drug release via poly(ε-caprolactone) and hydroxyapatite hybrid coatings. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 2004, 70B(2): 240~249
[127] Zhang LF, Yang DJ, Chen HC, et al. An ionically crosslinked hydrogel containing vancomycin coating on a porous scaffold for drug delivery and cell culture. International Journal of Pharmaceutics, 2008, 353(1-2):74~87
[128] Wei GB, Jin QM, Giannobile WV, et al. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. Journal of Controlled Release, 2006, 112(1): 103~110
[129] Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science, 2000, 289(5484): 1508~1514
[130] Patel ZS, Ueda H, Yamamoto M, et al. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharmaceutical Research, 2008, 25(10): 2370~2378
[131] Langer R. Drug delivery systems. MRS Bull XVI, 1991, (9): 47~49
[132] Chellat F, Tabrizian M, Dumitriu S, et al. Study of biodegradation behavior of chitosan-xanthan microspheres in simulated physiological media. Journal of Biomedical Materials Research, 2000, 53(5): 592~599.
[133] Silver GA, Ducheyne P, Reis RL. Materials in particulate form for tissue engineering. 1. Basic concepts. Journal of Tissue Engineering and Regenerative Medicine, 2007, 1(1): 4~24
[134] Grassi M, Colombo I, Lapasin R. Experimental determination of the theophylline diffusion coefficient in swollen sodium-alginate membranes. Journal of Controlled Release, 2001, 76(1-2): 93~105
[135] Berkland C, King M, Cox A, et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. Journal of Controlled Release, 2002, 82(1): 137~147
[136] Simmons CA, Alsberg E, Hsiong S, et al. Dual growth factor delivery and controlled scaffold degrad,ation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone, 2004, 35(2): 562~569
[137] Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair. International Journal of Developmental Biology, 1993, 37(4): 573~579
[138] Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. Journal of Cellular Biochemistry, 2003, 88(5): 873~884
[139] Raiche AT, Puleo DA. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials, 2004, 25(4): 677~685
[140] Bostrom MPG, Lane JM, Berberian WS, et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. Journal of Orthopaedic Research, 1995, 13(3):357~367
[141] Bourque WT, Gross M, Hall BK. Expression of four growth factors during fracture repair, International Journal of Developmental Biology, 1993, 37(4): 573~579
[142] Yu Y, Yang JL, Chapman-Sheath PJ, et al. TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing. Journal of Biomedical Materials Research, 2002, 60(3): 392~397
[143] Jaklenec A, Hinckfuss A, Bilgen B, et al. Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds. Biomaterials, 2008, 29(10): 1518~1525
[144] Yeh LCC, Adamo ML, Olson MS, et al. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology, 1997, 138(10):4181~4190
[145] Yeh LCC, Zavala MC, Lee JC. Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. Journal of Cellular Physiology, 2002, 190(3): 322~331
[146] Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients withperiodontal disease. Journal of Periodontology, 1997, 68(12):1186~1193
[147] Takita H, Tsuruga E, Ono I, et al. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. European Journal of Oral Sciences, 1997, 105 (6):588~592
[148] Sohier J, Vlugt TJH, Cabrol N, et al. Dual release of proteins from porous polymeric scaffolds. Journal of Controlled Release, 2006, 111(1-2): 95~106
[149] Konishi M, Tabata Y, Kariya M, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. Journal of Controlled Release, 2005, 103(1):7~19
[150] Riley CM, Fuegy PW, Firpo MA, et al. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials, 2006, 27(35): 5935~5943
[151] Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials, 2008, 29(31): 4195~4204
[152] Tanaka SM, Li JL; Duncan RL, et al. Effects of broad frequency vibration on cultured osteoblasts. Journal of Biomechanics, 2003, 36(1): 73~80
[153] Yang YF, Zhao J, Zhao YH, et al. Formation of porous PLGA scaffolds by a combining method of thermally induced phase separation and porogen leaching. Journal of Applied Polymer Science, 2008, 109(2): 1232~1241
[154] Oh SH, Kang SG, Lee JH. Degradation behavior of hydrophilized PLGA scaffolds prepared by melt-molding particulate-leaching method: Comparison with control hydrophobic one. Journal of Materials Science-Materials in Medicine, 2006, 17(2):131~137
[155] Shi GX, Cai Q, Wang CY, et al. Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polymers for Advanced Technologies, 2002, 13(3-4): 227~232
[156] Hou QP, Grijpma DW, Feijen J. Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials, 2003, 24(11): 1937~1947
[157] Hua FJ, Kim GE, Lee JD, et al. Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid-liquid phase separation of a PLLA-dioxane-water system. Journal of Biomedical Materials Research, 2002, 63(2): 161~167
[158] Zhang R, Weng WJ, Du PY, et al. Effect of Pluronic F127 on the pore structure of macrocellular biodegradable polylactide foams. Polymers for Advanced Technologies, 2004, 15(7): 425~430
[159] Zhang JC, Wu LB, Jing DY, et al. A comparative study of porous scaffolds withcubic and spherical macropores. Polymer, 2005, 46(13):4979~4985
[160]孙蕊,张丽芳,杜建等.聚乳酸/β-磷酸三钙多孔复合支架的制备及性能研究.合成化学, 2004, 12(6): 536~539
[161] Li HY, Chang J. pH-compensation effect of bioactive inorganic fillers on the degradation of PLGA. Composites Science and Technology, 2005, 65(14): 2226~2232
[162] Chen VJ, Ma PX. The effect of surface area on the degradation rate of nano-fibrous poly(l-lactic acid) foams. Biomaterials, 2006, 27(20): 3708~3715
[163] Lu L, Garcia CA, Mikos AG. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. Journal of Biomedical Materials Reserch, 1999, 46(2): 236~244
[164] Fernandes ALP, Morais WA, Santos AIB, et al. The influence of oxidative degradation on the preparation of chitosan nanoparticles. Colloid and Polymer Science, 2005, 284(1):1~9
[165] Fan YJ, Nishida H, Shirai Y, et al. Thermal stability of poly (L-lactide): influence of end protection by acetyl group. Polymer Degradation and Stability, 2004, 84(1):143~149
[166] Kaczmarek H, Bajer K, Galka P, et al. Photodegradation studies of novel biodegradable blends based on poly(ethylene oxide) and pectin. Polymer Degradation and Stability, 2007, 92(11):2058~2069
[167] Akyuz A, Catalgil-Giz H, Giz AT. Kinetics of ultrasonic polymer degradation: Comparison of theoretical models with on-line data. Macromolecular Chemistry Physics, 2008, 209(8): 801~809
[168] Roy PK, Surekha P, Rajagopal C, et al. Studies on the photo-oxidative degradation of LDPE films in the presence of oxidised polyethylene. Polymer Degradation and Stability, 2007, 92(6):1151~1160
[169] Kaczmarek H, Podgorski A. The effect of UV-irradiation on poly(vinyl alcohol) composites with montmorillonite. Journal of Photochemistry Photobiology A-Chemistry, 2007, 191: 209~215
[170] Loo JSC, Ooi CP, Boey FYC. Degradation of poly(lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by electron beam radiation. Biomaterials, 2005, 26(12): 1359~1367
[171] Tanaka SM, Li JL, Duncan RL, et al, Effects of broad frequency vibration on cultured osteoblasts. Journal of Biomechanics, 2003, 36(1):73~80
[172]周茂生,齐新生.成骨细胞和支架材料复合的研究进展.国外医学生物医学工程分册,2005,28(4):226~229
[173]鲜苏琴,柴枫,赵铱民等.成骨细胞在快速成型技术构建的骨支架材料中粘附的实验研究.华西口腔医学杂志,2004,22(3):248~251
[174]邵英,张舵,荣莉等.聚L-乳酸/聚L-乳酸接枝纳米羟基磷灰石复合材料对成骨细胞黏附和增殖能力的影响.中国组织工程研究与临床康, 2009, 13(34): 6617~6621
[175] Douglas T, Pamula E, Hauk D, et al. Porous polymer/hydroxyapatite scaffolds: characterization and biocompatibility investigations. Journal of Materials Science-Materials in Medicine, 2009, 20(9): 1909~1915
[176] Rohanizadeh R, Swain MV, Mason RS. Gelatin sponges (Gelfoam (R)) as a scaffold for osteoblasts. Journal of Materials Science-Materials in Medicine, 2008, 19(3): 1173~1182
[177] Qu X, Cui WJ, Yang F, et al. The effect of oxygen plasma pretreatment and incubation in modified simulated body fluids on the formation of bone-like apatite on poly(lactide-co-glycolide) (70/30). Biomaterials, 2007, 28(1): 9~18
[178] Kim HW, Kim HE, Salih V, et al. Dissolution control and cellular responses of calcium phosphate coatings on zirconia porous scaffold. Journal of Biomedical Materials Research, 2004, 68A(3): 522~530
[179] Rosso F, Giordano A, Barbarisi M, et al. From cell-ECM interactions to tissue engineering. Journal of Cellular Physiology, 2004, 199(2): 174~180
[180] Teng SH, Lee EJ, Wang P, et al. Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2009, 90B(1): 275~282
[181] Niu XF, Feng QL, Wang MB, et al. In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide. Polymer Degradation and Stability, 2009, 94(2): 176~182
[182] Yang YY, Chung TS, Ng NP, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 2001, 22(3): 231~241
[183] Soriano I , Llabres M, Evora C. Release control of albumin from polylactic acid microspheres. International Journal of Pharmaceutics, 1995, 125(2): 223~230
[184] Bezemer JM, Grijpma DW, Dijkstra PJ, et al. Control of protein delivery from amphiphilic poly(ether ester) multiblock copolymers by varying their water content using emulsification techniques. Journal of Controlled Release, 2000, 66(2-3): 307~320
[185] Rafati H, Coombes AGA, Adler J, et al. Protein-loaded poly(DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. Journal of Controlled Release, 1997, 43(1): 89~102
[186] Whang K, Goldstick TK, Healy KE. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials, 2000, 21(14): 2545~2551
[187]Wei GB, Pettway GJ, McCauley LK, et al. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials, 2004, 25(2):345~352
[188] Kim JH, Bae YH. Albumin loaded microsphere of amphiphilic poly(ethylene glycol)/poly(α-ester) multiblock copolymer. European Journal of Pharmaceutical Sciences, 2004, 23(3): 245~251
[189] Lee KY, Peters MC, Mooney DJ. Controlled drug delivery from polymers by mechanical signals. Advanced Materials, 2001, 13(11): 837~839
[190] Chen LB, Jiang QB, Lu WX. Production of Redispersible Powdered by Spray-Drying Process. Paint&Coatings Industry. 2008, 38(2): 30-35
[191] Lin XN, Zhou RM, Qiao Y, et al. Poly(ethylene glycol)/poly(ethyl cyanoacrylate) amphiphilic triblock copolymer nanoparticles as delivery vehicles for dexamethasone. Polymer Chemistry, 2008, 46(23): 7809-7815
[192] Corre PL, Guevello PL, Gajan V, et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. International Journal of Pharmaceutics, 1994, 107(1): 41-49
[193] Zhao L, He C G, Gao Y J. Study on Influence of Copolymer Compositions of PLGA on Properties of Scaffolds. China Biotechnology, 2008, 28(5): 22-28
[194] Hickey T, Kreutzer D, Burgess D J, et al. Dexamethasone/PLGA microsphere for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials, 2002, 23(7): 1649-1656